Health Canada has approved the gene therapy Zolgensma that’s used to treat children with a rare degenerative neuromuscular disease. As Tracy Nagai reports, the news is providing a glimmer of hope for an Alberta family.
Health Canada approves gene therapy to treat spinal muscular atrophy
More Videos
-
Monday Motivation: The power of daily deposits
-
How to turn your leftovers into delicious new meals
-
Celebrate a high-tech holiday with your guide to the latest light technology
-
Canada Post strike enters 11th day
-
Biden pardons turkeys ‘Peach and Blossom’ in his last Thanksgiving as president
-
Witness hurt in stabbing outside Vancouver liquor store
You are viewing an Accelerated Mobile Webpage.
View Original Article